Mirexus Biotechnologies Inc. raises $12 million to finance factory, fund business development, and deepen R&D

Mirexus Biotechnologies Inc. (Mirexus) is excited to announce that it has closed an investment round of $12 million.  Mirexus is a safe and natural nanomaterials company based in Guelph, Ontario that is commercializing PhytoSpherix™, a novel technology based on polysaccharide nanoparticles that can be used in a wide variety of markets ranging from cosmetics to nutraceuticals to applications in human health.  The funds will be used to finance a factory to produce PhytoSpherix™, and to fund at least three years of operations as the company grows.

Boris Segalowitch joins Mirexus as Vice President Personal Care

Mirexus is pleased to announce that Boris Segalowitch has joined as Vice President Personal Care. Boris is based in Paris, France and will lead our efforts to expand the use of our innovative products into the Global Personal Care market. Boris brings over 20 years’ experience in Personal Care, including senior roles with some of the world’s leading Personal Care companies (most recently at Clariant and Croda).